LDL from obese patients with the metabolic syndrome show increased lipid peroxidation and activate platelets

Diabetologia

Volumn 54, Issue 11, 2011, Pages 2931-2940

  Colas, R ^a   Sassolas, A ^a,b   Guichardant, M ^a   Cugnet Anceau, C ^b   Moret, M ^b   Moulin, P ^a,b   Lagarde, M ^a   Calzada, C ^a  

^a CarMeN   (France)

^b HOSPICES CIVILS DE LYON   (France)

Author keywords

Fatty acids; LDL; Lipid peroxidation; Metabolic syndrome; Obesity; Oxidised LDL; Platelets; Type 2 diabetes

Indexed keywords

ALPHA TOCOPHEROL; ARACHIDONIC ACID; C REACTIVE PROTEIN; CHOLESTEROL ESTER; ETHANOLAMINE; FATTY ACID; LINOLEIC ACID; LIPID; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLCHOLINE; PHOSPHOLIPASE A2; PLASMALOGEN; THROMBOXANE B2; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FATTY ACID OXIDATION; HUMAN; HUMAN CELL; LIPID COMPOSITION; LIPID PEROXIDATION; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

ADULT; AGED; ARACHIDONIC ACID; BIOLOGICAL MARKERS; BLOOD PLATELETS; DIABETES MELLITUS, TYPE 2; HUMANS; LIPID PEROXIDATION; LIPIDS; LIPOPROTEINS, LDL; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; OXIDATIVE STRESS; PHOSPHOLIPASES A2, SECRETORY; PLATELET ACTIVATION; SIGNAL TRANSDUCTION;

EID: 80054686061     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-011-2272-8     Document Type: Article

References (47)

1. JW Stephens MP Khanolkar SC Bain 2009 The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease Atherosclerosis 202 321 329 18640680 10.1016/j.atherosclerosis.2008.06. 006 1:CAS:528:DC%2BD1MXhtFehurk%3D
2. RM Hsu S Devaraj I Jialal 2002 Autoantibodies to oxidized low-density lipoprotein in patients with type 2 diabetes mellitus Clin Chim Acta 317 145 150 11814469 10.1016/S0009-8981(01)00767-7 1:CAS:528:DC%2BD38Xos1GisA%3D%3D (Pubitemid 34114029)
3. R Colas V Pruneta-Deloche M Guichardant, et al. 2010 Increased lipid peroxidation in LDL from type-2 diabetic patients Lipids 45 723 731 20703822 10.1007/s11745-010-3453-9 1:CAS:528:DC%2BC3cXhtVamt7bI
4. P Holvoet SB Kritchevsky RP Tracy, et al. 2004 The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort Diabetes 53 1068 1073 15047623 10.2337/diabetes.53.4.1068 1:CAS:528:DC%2BD2cXivFyqsbk%3D (Pubitemid 38436620)
5. V Sigurdardottir B Fagerberg J Hulthe 2002 Circulating oxidized low-density lipoprotein (LDL) is associated with risk factors of the metabolic syndrome and LDL size in clinically healthy 58-year-old men (AIR Study) J Intern Med 252 440 447 12528762 10.1046/j.1365-2796.2002.01054.x 1:CAS:528: DC%2BD38XptVOmsLY%3D (Pubitemid 36706575)
6. SH Park JY Kim JH Lee HY Park 2011 Elevated oxidized low-density lipoprotein concentrations in postmenopausal women with the metabolic syndrome Clin Chim Acta 412 435 440 21093421 10.1016/j.cca.2010.11.017 1:CAS:528:DC%2BC3MXkt1Wksw%3D%3D
7. B Hansel P Giral E Nobecourt, et al. 2004 Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity J Clin Endocrinol Metab 89 4963 4971 15472192 10.1210/jc.2004-0305 1:CAS:528: DC%2BD2cXovVemsrg%3D (Pubitemid 39391435)
8. P Sjogren S Basu M Rosell, et al. 2005 Measures of oxidized low-density lipoprotein and oxidative stress are not related and not elevated in otherwise healthy men with the metabolic syndrome Arterioscler Thromb Vasc Biol 25 2580 2586 16224051 10.1161/01.ATV.0000190675.08857.3d 1:CAS:528:DC%2BD2MXht1Crt7vM (Pubitemid 43732282)
9. RC Seet CY Lee EC Lim, et al. 2010 Markers of oxidative damage are not elevated in otherwise healthy individuals with the metabolic syndrome Diabetes Care 33 1140 1142 20185735 10.2337/dc09-2124 1:CAS:528:DC%2BC3cXnsFyltrY%3D
10. PW Wilson RB DAgostino H Parise L Sullivan JB Meigs 2005 Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus Circulation 112 3066 3072 16275870 10.1161/CIRCULATIONAHA.105.539528 1:CAS:528:DC%2BD2MXhtF2rtbfL (Pubitemid 43113437)
11. AS Gami BJ Witt DE Howard, et al. 2007 Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies J Am Coll Cardiol 49 403 414 17258085 10.1016/j.jacc.2006.09.032 1:CAS:528:DC%2BD2sXhtVCks7s%3D (Pubitemid 46135879)
12. E Vericel C Januel M Carreras P Moulin M Lagarde 2004 Diabetic patients without vascular complications display enhanced basal platelet activation and decreased antioxidant status Diabetes 53 1046 1051 15047620 10.2337/diabetes.53. 4.1046 1:CAS:528:DC%2BD2cXivFyqsbo%3D (Pubitemid 38436617)
13. M Vaduganathan CL Alviar ME Arikan, et al. 2008 Platelet reactivity and response to aspirin in subjects with the metabolic syndrome Am Heart J 156 1002 e1001 1002 e1007 10.1016/j.ahj.2008.08.002
14. D Vaidya LR Yanek N Faraday TF Moy LC Becker DM Becker 2009 Native platelet aggregation and response to aspirin in persons with the metabolic syndrome and its components Metab Syndr Relat Disord 7 289 296 19351291 10.1089/met.2008.0083 1:CAS:528:DC%2BD1MXpsFygtLY%3D
15. C Calzada E Vericel B Mitel L Coulon M Lagarde 2001 12(S)-Hydroperoxy- eicosatetraenoic acid increases arachidonic acid availability in collagen-primed platelets J Lipid Res 42 1467 1473 11518767 1:CAS:528:DC%2BD3MXmslSqtb4%3D (Pubitemid 34007678)
16. L Coulon C Calzada P Moulin E Vericel M Lagarde 2003 Activation of p38 mitogen-activated protein kinase/cytosolic phospholipase A2 cascade in hydroperoxide-stressed platelets Free Radic Biol Med 35 616 625 12957654 10.1016/S0891-5849(03)00386-1 1:CAS:528:DC%2BD3sXmvV2rtr8%3D (Pubitemid 37101129)
17. JW Akkerman 2008 From low-density lipoprotein to platelet activation Int J Biochem Cell Biol 40 2374 2378 18468940 10.1016/j.biocel.2008.04.002 1:CAS:528:DC%2BD1cXpsVagur4%3D
18. G Ferretti RA Rabini T Bacchetti, et al. 2002 Glycated low density lipoproteins modify platelet properties: a compositional and functional study J Clin Endocrinol Metab 87 2180 2184 11994361 10.1210/jc.87.5.2180 1:CAS:528:DC%2BD38XjsFGhur4%3D (Pubitemid 34521506)
19. J Watanabe HJ Wohltmann RL Klein JA Colwell MF Lopes-Virella 1988 Enhancement of platelet aggregation by low-density lipoproteins from IDDM patients Diabetes 37 1652 1657 3192039 10.2337/diabetes.37.12.1652 1:CAS:528:DyaL1MXlsFartQ%3D%3D (Pubitemid 19004949)
20. C Calzada L Coulon D Halimi, et al. 2007 In vitro glycoxidized low-density lipoproteins and low-density lipoproteins isolated from type 2 diabetic patients activate platelets via p38 mitogen-activated protein kinase J Clin Endocrinol Metab 92 1961 1964 17341567 10.1210/jc.2006-2045 1:CAS:528:DC%2BD2sXlt1Oku70%3D (Pubitemid 47007543)
21. SM Grundy B Hansen SC Smith Jr JI Cleeman RA Kahn 2004 Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association Conference on Scientific Issues Related to Management Circulation 109 551 556 14757684 10.1161/01.CIR.0000112379.88385.67 (Pubitemid 38168522)
22. RJ Havel HA Eder JH Bragdon 1955 The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum J Clin Invest 34 1345 1353 13252080 10.1172/JCI103182 1:CAS:528:DyaG28XitFyn
23. MM Bradford 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 248 254 942051 10.1016/0003-2697(76)90527-3 1:CAS:528: DyaE28XksVehtrY%3D
24. RW Browne D Armstrong 2000 HPLC analysis of lipid-derived polyunsaturated fatty acid peroxidation products in oxidatively modified human plasma Clin Chem 46 829 836 10839772 1:CAS:528:DC%2BD3cXkt1ejtbo%3D (Pubitemid 30397447)
25. J Therasse F Lemonnier 1987 Determination of plasma lipoperoxides by high-performance liquid chromatography J Chromatogr 413 237 241 3558674 10.1016/0378-4347(87)80232-3 1:CAS:528:DyaL2sXhslahsr4%3D (Pubitemid 17005012)
26. M Lagarde PA Bryon M Guichardant M Dechavanne 1980 A simple and efficient method for platelet isolation from their plasma Thromb Res 17 581 588 7368178 10.1016/0049-3848(80)90098-5 1:STN:280:DyaL3c7mvFOjtg%3D%3D (Pubitemid 10129052)
27. GV Born 1962 Aggregation of blood platelets by adenosine diphosphate and its reversal Nature 194 927 929 13871375 10.1038/194927b0 1:CAS:528: DyaF38XksVGht70%3D
28. B Engelmann C Brautigam J Thiery 1994 Plasmalogen phospholipids as potential protectors against lipid peroxidation of low density lipoproteins Biochem Biophys Res Commun 204 1235 1242 7980601 10.1006/bbrc.1994.2595 1:CAS:528:DyaK2cXmvFyhurw%3D
29. B Engelmann UM Schonthier WO Richter J Duhm 1992 Changes of membrane phospholipid composition of human erythrocytes in hyperlipidemias. II. Increases in distinct molecular species of phosphatidylethanolamine and phosphatidylcholine containing arachidonic acid Biochim Biophys Acta 1165 38 44 1420346 1:CAS:528:DyaK3sXnvVektw%3D%3D
30. U Dreissigacker MT Suchy N Maassen D Tsikas 2010 Human plasma concentrations of malondialdehyde (MDA) and the F2-isoprostane 15(S)-8-iso-PGF(2alpha) may be markedly compromised by hemolysis: evidence by GC-MS/MS and potential analytical and biological ramifications Clin Biochem 43 159 167 19850019 10.1016/j.clinbiochem.2009.10.002 1:CAS:528:DC%2BC3cXoslal
31. SW Walsh JE Vaughan Y Wang LJ Roberts 2nd 2000 Placental isoprostane is significantly increased in preeclampsia FASEB J 14 1289 1296 10877821 10.1096/fj.14.10.1289 1:CAS:528:DC%2BD3cXks12jtLs%3D (Pubitemid 30439737)
32. A Griesmacher M Kindhauser SE Andert, et al. 1995 Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus Am J Med 98 469 475 7733126 10.1016/S0002-9343(99)80347-7 1:STN:280:DyaK2M3ltVyjsg%3D%3D
33. MC Garin B Kalix A Morabia RW James 2005 Small, dense lipoprotein particles and reduced paraoxonase-1 in patients with the metabolic syndrome J Clin Endocrinol Metab 90 2264 2269 15687341 10.1210/jc.2004-1295 1:CAS:528:DC%2BD2MXjsFWju7w%3D (Pubitemid 40586272)
34. M Gentile S Panico F Jossa, et al. 2008 Small dense LDL particles and metabolic syndrome in a sample of middle-aged women. Findings from Progetto Atena Clin Chim Acta 388 179 183 18035055 10.1016/j.cca.2007.10.033 1:CAS:528:DC%2BD2sXhsVOltLjO (Pubitemid 350266592)
35. DL Tribble LG Holl PD Wood RM Krauss 1992 Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size Atherosclerosis 93 189 199 1590824 10.1016/0021-9150(92)90255-F 1:CAS:528:DyaK38XksVGkur4%3D
36. ES Ford AH Mokdad WH Giles DW Brown 2003 The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey Diabetes 52 2346 2352 12941775 10.2337/diabetes.52. 9.2346 1:CAS:528:DC%2BD3sXntFequr0%3D (Pubitemid 37059506)
37. C Feillet-Coudray E Rock C Coudray, et al. 1999 Lipid peroxidation and antioxidant status in experimental diabetes Clin Chim Acta 284 31 43 10437641 10.1016/S0009-8981(99)00046-7 1:CAS:528:DyaK1MXjvFCisL0%3D (Pubitemid 29324863)
38. ES Ford 2006 Intake and circulating concentrations of antioxidants in metabolic syndrome Curr Atheroscler Rep 8 448 452 17045069 10.1007/s11883-006- 0018-8 1:CAS:528:DC%2BD28Xht1Cnu7bF (Pubitemid 44697796)
39. D Hahnel K Beyer B Engelmann 1999 Inhibition of peroxyl radical-mediated lipid oxidation by plasmalogen phospholipids and alpha-tocopherol Free Radic Biol Med 27 1087 1094 10569641 10.1016/S0891-5849(99)00142-2 1:CAS:528:DyaK1MXns1yms7c%3D (Pubitemid 29507481)
40. Z Mallat G Lambeau A Tedgui 2010 Lipoprotein-associated and secreted phospholipases A in cardiovascular disease: roles as biological effectors and biomarkers Circulation 122 2183 2200 21098459 10.1161/CIRCULATIONAHA.110.936393
41. N Mattsson CG Magnussen T Ronnemaa, et al. 2010 Metabolic syndrome and carotid intima-media thickness in young adults: roles of apolipoprotein B, apolipoprotein A-I, C-reactive protein, and secretory phospholipase A2: the cardiovascular risk in young Finns study Arterioscler Thromb Vasc Biol 30 1861 1866 20539018 10.1161/ATVBAHA.110.204669 1:CAS:528:DC%2BC3cXhtVCnsbjN
42. AG Borsch-Haubold RM Kramer SP Watson 1997 Phosphorylation and activation of cytosolic phospholipase A2 by 38-kDa mitogen-activated protein kinase in collagen-stimulated human platelets Eur J Biochem 245 751 759 9183015 10.1111/j.1432-1033.1997.t01-1-00751.x 1:CAS:528:DyaK2sXjt12hs7k%3D (Pubitemid 27223910)
43. 2+-sensitive cytosolic phospholipase A2 (cPLA2) FEBS Lett 410 49 53 9247121 10.1016/S0014-5793(97)00322-0 1:CAS:528:DyaK2sXkt1Shurg%3D (Pubitemid 27283382)
44. C Calzada E Vericel M Lagarde 1997 Low concentrations of lipid hydroperoxides prime human platelet aggregation specifically via cyclo-oxygenase activation Biochem J 325 495 500 9230133 1:CAS:528:DyaK2sXkvFCktr0%3D (Pubitemid 27338733)
45. EA Podrez TV Byzova M Febbraio, et al. 2007 Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype Nat Med 13 1086 1095 17721545 10.1038/nm1626 1:CAS:528:DC%2BD2sXhtVSgtrrF (Pubitemid 47517507)
46. N Sattar A Gaw O Scherbakova, et al. 2003 Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study Circulation 108 414 419 12860911 10.1161/01.CIR.0000080897.52664.94 1:CAS:528:DC%2BD3sXlsFOjt7s%3D (Pubitemid 36935533)
47. NF Wiernsperger 2003 Oxidative stress as a therapeutic target in diabetes: revisiting the controversy Diabetes Metab 29 579 585 14707886 10.1016/S1262-3636(07)70072-1 1:STN:280:DC%2BD2c%2FmtFOrtw%3D%3D (Pubitemid 38082159)